Tags

Type your tag names separated by a space and hit enter

[Progression of treatment and researches in dry age related macular degeneration].
Zhonghua Yan Ke Za Zhi. 2015 Mar; 51(3):236-40.ZY

Abstract

Age related macular degeneration (AMD) is the leading cause of blindness and visual disability among old patients in Europe and North America. AMD has been divided into two broad clinical categories depending on whether there is a presence of abnormal neovascularization: neovascular (exudative or wet) AMD and dry (or geographic atrophic) AMD. VEGF has been understood as a pathogenesis of wet AMD which allows us to get breakthroughs in treatment. While the progression of dry AMD treatment is very slow because the lack of pathogenesis, no acute loss of vision, and without appropriate standards for treatment. This review tries to introduce about the recent researches and progressions for dry AMD treatment.

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

chi

PubMed ID

26268648

Citation

Zhang, Kaiyan, and Shibo Tang. "[Progression of Treatment and Researches in Dry Age Related Macular Degeneration]." [Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology, vol. 51, no. 3, 2015, pp. 236-40.
Zhang K, Tang S. [Progression of treatment and researches in dry age related macular degeneration]. Zhonghua Yan Ke Za Zhi. 2015;51(3):236-40.
Zhang, K., & Tang, S. (2015). [Progression of treatment and researches in dry age related macular degeneration]. [Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology, 51(3), 236-40.
Zhang K, Tang S. [Progression of Treatment and Researches in Dry Age Related Macular Degeneration]. Zhonghua Yan Ke Za Zhi. 2015;51(3):236-40. PubMed PMID: 26268648.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Progression of treatment and researches in dry age related macular degeneration]. AU - Zhang,Kaiyan, AU - Tang,Shibo, PY - 2015/8/14/entrez PY - 2015/8/14/pubmed PY - 2015/10/10/medline SP - 236 EP - 40 JF - [Zhonghua yan ke za zhi] Chinese journal of ophthalmology JO - Zhonghua Yan Ke Za Zhi VL - 51 IS - 3 N2 - Age related macular degeneration (AMD) is the leading cause of blindness and visual disability among old patients in Europe and North America. AMD has been divided into two broad clinical categories depending on whether there is a presence of abnormal neovascularization: neovascular (exudative or wet) AMD and dry (or geographic atrophic) AMD. VEGF has been understood as a pathogenesis of wet AMD which allows us to get breakthroughs in treatment. While the progression of dry AMD treatment is very slow because the lack of pathogenesis, no acute loss of vision, and without appropriate standards for treatment. This review tries to introduce about the recent researches and progressions for dry AMD treatment. SN - 0412-4081 UR - https://www.unboundmedicine.com/medline/citation/26268648/[Progression_of_treatment_and_researches_in_dry_age_related_macular_degeneration]_ L2 - http://journal.yiigle.com/LinkIn.do?linkin_type=pubmed&issn=0412-4081&year=2015&vol=51&issue=3&fpage=236 DB - PRIME DP - Unbound Medicine ER -